Live
FierceBiotech'Biopharma ecosystem is back to full health,' fueled by M&A: PwCFierceBiotechJazz, AbCellera strike TCE discovery and development deal worth up to $792M per drugEndpoints NewsJazz turns to AbCellera for T cell engagers in up to $4.1B partnershipEndpoints NewsSpot Bio launches with $40M to study mRNA therapy for muscular dystrophyEndpoints NewsTriveni Bio raises $65M ahead of upcoming readouts on eczema drugsCellCellular architecture and neighborhood-informed virtual spatial tumor profiling from histopathologyCellA CRISPR knockout mouse library for functional genomics in influenza researchEndpoints NewsMigraine biotech Vedana Therapeutics makes its debut with $46M Series ABioPharma DiveA new Westlake-backed biotech takes aim at migraineseLifeTracheal terminal cells of <i>Drosophila</i> are immune privileged to maintain their Foxo-dependent structural plasticityeLifeCorrection: The myeloid cell-driven transdifferentiation of endothelial cells into pericytes promotes the restoration of BBB function and brain self-repair after stroke10x Genomics NewsTXG (Nasdaq) RSU vesting entries listed on Form 144 with JP Morgan intermediary - Stock Titan

Archiv

Aktuell Älteste
Gesamt 13460
Seite 103 / 748
Suche --